¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Jewish social studies."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® social phobia ÇÑ±Û »çȸ°øÆ÷
¼³¸í   
  ´Ù¸¥ »ç¶÷µéÀÌ Àڱ⸦ »ìÇǰí ÃÄ´Ù º¼¼ö Àִ »óȲÀ» µÎ·Á¿öÇÏ°í ±×·± »óȲ¿¡ Ã³Çϸ頼öÄ¡½ÉÀ» ´À³¢´Â °øÆ÷Àå¾Ö(phobic disorder)ÀÇ ÀÏÁ¾. »ç¶÷À» ¸¸³ª±â Àü¿¡ ¹Ì¸® ¿¹»óÇÏ°í ºÒ¾È(anticipatory anxiety: ¿¹»óÀ» Çϴ °Í ÀÚü¸¸À¸·Î ºÒ¾ÈÀ» ´À³¢´Â °Í)À» ½ÉÇϰԠ´À³¢¹Ç·Î »ç¶÷°ú Á¢ÃËÇϴ °ÍÀ» ÇÇÇÑ´Ù. ÈçÇÑ »çȸ °øÆ÷ÁõÀ¸·Î´Â »ç¶÷¾Õ¿¡¼­ ¸»Çϱ⸦ µÎ·Á¿öÇϴ ´ëÈ­°øÆ÷(fear of public speaking), »ç¶÷¾Õ¿¡¼­ ¾ó±¼À» ºÓÈ÷´Â °ÍÀ» µÎ·Á¿öÇϴ Àû¸é°øÆ÷(erythrophobia), »ç¶÷ ¾Õ¿¡¼­ÀÇ ½Ä»ç¸¦ µÎ·Á¿öÇϴ ½Ä»ç°øÆ÷(sitophobia), »ç¶÷ ¾Õ¿¡¼­ÀÇ ±Û ¾²±â¸¦ µÎ·Á¿öÇϴ ¼­ÇʰøÆ÷, °øÁߺ¯¼Ò¸¦ »ç¿ëÇϱ⸦ µÎ·Á¿öÇϴ °øÁߺ¯¼Ò°øÆ÷µîÀÌ ÀÖÀ½. ÀÌ Àå¾Ö´Â ¾Æµ¿±â ÈĹݠȤÀº »çÃá±â Ãʹݿ¡ ½ÃÀ۵Ǹ砰¡Á·ÀûÀ¸·Î ¹ßº´Çϴ °æÇâÀÌ ¸¹´Ù. ÇÕº´ÁõÀ¸·Î´Â °úÀ½, Ç׺ҾȠ¾à¹° ³²¿ë µîÀÌ ÀÖ´Ù.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cognitive social learning
    ÀÎÁö»çȸÇнÀ
  • medical social work
    ÀÇ·á»çȸ»ç¾÷
  • social service model
    »çȸ¼­ºñ½º¸ðµ¨
  • social skills training
    »çȸ±â¼úÈÆ·Ã
  • social withdrawal
    »çȸÀûÀ§Ãà
  • social
    »çȸ-
  • social adjustment
    »çȸÀûÀÀ
  • social adjustment scale
    »çȸÀûÀÀôµµ
  • social class
    »çȸ°èÃþ
  • social clock
    »çȸÀû½Ã°è
  • social hygiene
    »çȸÀ§»ý
  • social integration
    »çȸÀûÅëÇÕ
  • social learning theory
    »çȸÇнÀÀÌ·Ð
  • social medicine
    »çȸÀÇÇÐ
  • social mobility
    »çȸÀ̵¿µµ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • social adjustment
    »çȸÀûÀÀ
  • social class
    »çȸ°èÃþ
  • social medicine
    »çȸÀÇÇÐ
  • skill social
    »çȸ±â¼ú
  • social
    »çȸ-
  • social security
    »çȸº¸ÀåÁ¦µµ, »çȸº¸Àå¹ý
  • medical social worker
    ÀÇ·á»çȸ»ç¾÷°¡
  • social withdrawal
    »çȸÀûÀ§Ãà
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • social adjustment
    »çȸÀûÀÀ
  • social security act
    »çȸº¸Àå¹ý, »çȸº¸Àå¹ý
  • cognitive social learning
    ÀÎÁö»çȸÇнÀ
  • social class
    »çȸ°èÃþ
  • social clock
    »çȸÀû½Ã°è
  • social hygiene
    »çȸÀ§»ý
  • social causation hypothesis
    »çȸ¿øÀΰ¡¼³
  • social integration
    »çȸÀûÅëÇÕ
  • social network intervention
    »çȸÁöÁö¸ÁÁ¶Á¤
  • medical social work
    ÀÇ·á»çȸ»ç¾÷
  • medical social worker
    ÀÇ·á»çȸ»ç¾÷°¡
  • social medicine
    »çȸÀÇÇÐ
  • social mobility
    »çȸÀ̵¿µµ
  • social service model
    m. »çȸ¼­ºñ½º¸ðµ¨
  • social psychiatry
    »çȸÁ¤½ÅÀÇÇÐ, »çȸÁ¤½Å°úÇÐ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • SOFAS, Social and Occupational Functioning Assessment Scale
    »çȸ-Á÷¾÷±â´ÉÆò°¡Ã´µµ
  • gastric acid secretory studies
    À§»êºÐºñ °Ë»ç.
  • real-time studies
    ½Ç½Ã°£ °Ë»ç (ãùãÁÊà ËþÞÛ)
  • releaser, social
    º»´ÉÀ¯¹ßÀÎÀÚ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gastric acid secretory studies
    À§»êºÐºñ °Ë»ç.
  • real-time studies
    ½Ç½Ã°£ °Ë»ç (ãùãÁÊà ËþÞÛ)
  • chronic social breakdown syndrome
    ¸¸¼º »çȸ¼º ºØ±«ÁõÈıº
  • cognitive social learning
    ÀÎÁö»çȸÇнÀ(ìãò±ÞäüåùÊã§)
  • medical social service department
    ÀÇ·á»ç ȸ»ç¾÷ºÎ(ÊÙË×Ì·Ë×ËâËÓ).
  • medical social work
    ÀÇ·á»çȸ»ç¾÷(ÊÙË×Ì· Ë×Ëâ).
  • medical social worker
    ÀÇ·á»çȸ»ç¾÷°¡(ÊÙË× Ëâ˧).
  • mobility, social
    »çȸÀ̵¿(µµ).
  • neurosis,social
  • releaser, social
    º»´ÉÀ¯¹ßÀÎÀÚ.
  • social adaptation
    »çȸÀû ¼øÀÀ(¡­â÷ëë).
  • social adequacy index
    »çȸÀû¼º Áö¼ö(ÊÙËøËṲ̂Ëà).
  • social adjustment
    »çȸÀû Á¶Á¤(¡­ðàïÚ).
  • social adjustment scale-II(SAS-II)
    »çȸÀûÀÀôµµ-II
  • social and cultural psychiatry
    »çȸ ¹× ¹®È­Á¤½ÅÀÇÇÐ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MSW Master of Social Welfare; Master of Social Work; medical social worker; multiple stab wounds
SRS schizophrenic residual state; sex reassignment surgery; Silver-Russell syndrome; simple repeat seque...
SS disulfide; sacrosciatic; saline soak; saline solution; saliva sample; saliva substitute; Salmonella-...
CAS calcarine sulcus; calcific aortic stenosis; Cancer Attitude Survey; carbohydrate-active steroid; car...
CES-D Center for Epidemiological Studies of Depression [scale]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CES-D Center for Epidemiologic Studies - Depression
CES-D Center for Epidemiologic Studies - Depression Scale
CES-D Center for Epidemiological Studies Depression
CESD Centers for Epidemiological Studies Depression Scale
EPS Electrophysiologic Studies
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 24267
    JournalTitle: Jewish social studies.
    MedAbbr: Jew Soc Stud
    ISSN: 0021-6704
    ESSN:
    IsoAbbr:
    NlmId: 100968226
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • impaired social activity
    »çȸÀû Ȱµ¿ Àå¾Ö
  • medical social service department
    ÀÇ·á»çȸ»ç¾÷ºÎ
  • social
    »çȸ
    ¼­·Î Çù·ÂÇÏ¿© °øµ¿ »ýȰÀ» ÇÏ´Â ÀηùÀÇ Áý´Ü ¶Ç´Â ¿Â°® ÇüÅÂÀÇ Àΰ£ÀÇ Áý´ÜÀû »ýȰ. ÀÚ¿¬ÀûÀ¸·Î ¹ß»ýµÈ Áý´Ü°ú ÀÎÀ§ÀûÀ¸·Î ƯÁ¤ÇÑ ÀÌÇØ ¹× ¸ñÀûÀ» °¡Áö°í Çü¼ºÇÑ Áý´ÜÀÇ µÑ·Î ³ª´­ ¼ö ÀÖ´Ù.
  • social behavior
    »çȸÀû Çൿ, »çȸ Çൿ
  • social breakdown syndrome
    »çȸ ºÐÇØ ÁõÈıº
    ȯÀÚÀÇ Á¤½Å Áõ»óÀÌ, ƯÈ÷ Å©°í Ä¡·á ¿ä¿øµéÀÌ ÀûÀº º´¿ø¿¡¼­, ¿øÀÎ Áúȯ ¿Ü¿¡ Ä¡·á ȯ°æ°ú ¼³ºñ¿¡ ´ëÇÑ °á°ú·Î ÇÏ´Â °³³äÀ» Ç¥ÇöÇÏ´Â µ¥ »ç¿ëµÇ´Â ¿ë¾î.
  • social conflict
    »çȸ °¥µî
  • social history
    »çȸ·Â
  • social introversion
    »çȸÀû ³»Ç⼺
  • social medicine
    »çȸ ÀÇÇÐ
  • social morality
    »çȸ µµ´ö
  • social phobia
    »çȸ °øÆ÷Áõ
  • social psychiatry
    »çȸ Á¤½Å ÀÇÇÐ
  • social readjustment rating scale
    »çȸ ÀçÀûÀÀ Æò°¡ ôµµ
  • social situation
    »çȸÀûÀÎ »óȲ
  • social welfare activity
    »çȸ º¹Áö»ç¾÷
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
retrospective studies Studies used to test aetiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
(12 Dec 1998)
pharmalogical studies <pharmacology> Studies to assess the potential harmful or other effects of drugs
(16 Dec 1997)
clinical studies <pharmacology> Human studies that are designed to measure the safety, efficacy, and appropriate dosage of a new drug or biological. Clinical studies routinely involve the use of a placebo group that is given an inactive substance that looks like the test product.
(14 Nov 1997)
cohort studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesised to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
(12 Dec 1998)
combination studies <pharmacology> Studies in which a new drug is evaluated in combination with existing drugs.
(09 Jan 1998)
multicenter studies Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children.
(12 Dec 1998)
multivariate studies The use of statistical techniques for the simultaneous investigations of the influence of several variables.
(05 Mar 2000)
preclinical studies <pharmacology> Studies in which a drug is tested on animals and in other non-human test systems. Safety information from such studies are used to support an investigational new drug application.
(14 Nov 1997)
sampling studies Studies in which a number of subjects are selected from all subjects in a defined population. Conclusions based on sample results may be attributed only to the population sampled.
(12 Dec 1998)
prospective studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
(12 Dec 1998)
his bundle studies <cardiology> This test studies the electrical activity of the bundle of HIS.
The bundle of HIS is a group of electrical fibres in the heart that are responsible for transmitting the electrical impulses which generate a normal cardiac contraction. This test may be performed in cases of cardiac arrhythmias, to locate a specific area responsible for a conduction defect and to determine the need for cardiac pacemaker placement.
The test involves the passage of a an electrode tipped catheter into the heart. This catheter is usually threaded through a neck, arm or chest vein. Measurements of the HIS bundle can then be performed while standard ECG leads are placed on the arms and legs.
This test carries a small risk of bleeding, arrhythmias, embolism, heart attack and stroke. It is performed by a specially trained cardiologist.
(27 Sep 1997)
immunofluorescent studies <technique> A special assay that relies on the production of measurable fluorescent light. An immunofluorescent tagged antibody interacts and binds with an antigen allowing an indirect measurement of its concentration.
(27 Sep 1997)
intervention studies Epidemiologic investigations designed to test a hypothesised cause-effect relation by modifying the supposed causal factor(s) in the study population.
(12 Dec 1998)
intracardiac electrophysiology studies <cardiology, investigation> A special study that involves the placement of electrodes inside the heart to map the electrical characteristics of the heart.
This study is carried out in a specially equipped lab and is similar to a cardiac catheterisation procedure. Electrodes are placed inside the heart via a catheter placed into a vein. The electrodes are positioned near the heart's conduction system and an electrical map of the heart can be determined.
This test is often performed in those where a life-threatening cardiac arrhythmia is a problem. The location and characteristics of an arrhythmia can be determined, thus guiding medical management of the problem. Patients with Wolf Parkinson White syndrome or sick sinus syndrome may have this test as part of their evaluation.
(27 Sep 1997)
organizational case studies Descriptions and evaluations of specific health care organizations.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • jewish
    À¯´ëÀÎÀÇ
  • International Institute for Strategic Studies
    (¿µ)±¹Á¦ Àü·«¿¬±¸¼Ò(I.I.S.S)
  • Jewish
    À¯´ëÀÎÀÇ;È÷ºê¸®ÀÎÀÇ
  • peace studies
    ÆòÈ­ ¿¬±¸(°­ÁÂ)
  • social
    »çȸÀÇ,»ç±³ÀûÀÎ
  • Economic and Social Council
    =ECOSOC
  • Social Credit
    »çȸ ä±Ç¼³
  • Social Democracy
    »çȸ ¹ÎÁÖÁÖÀÇ
  • Social Register
    ¸í»ç·Ï
  • social
    »çȸÀÇ(¿¡ °üÇÑ);»çȸ(»ç±³)ÀûÀÎ;ºÙÀÓ¼º ÀÖ´Â;»çȸÁÖÀÇÀÇ;»çȸ»ýȰÀ» ¿µÀ§ÇÏ´Â;Ä£¸ñȸ
  • social climber
    Ãâ¼¼ÁÖÀÇÀÚ;¾ß½É°¡
  • social disease
    ¼ºº´
  • social distance
    (¹ÎÁ·°£ÀÇ)»çȸÀû °Å¸®
  • social dynamics
    »çȸ ¿ªÇÐ
  • social engineering
    »çȸ °øÇÐ(»çȸ ±¸Á¶ °³¼±ÀÇ ¿¬±¸)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á